AFP and liver cancer: The patient characteristics retrieved from two trials were similar, and no significant differences were found in sex, age, ECOG performance status, plasma levels of α-fetoprotein (AFP), Barcelona Clinic Liver Cancer stages B and C, percentage of Child-Pugh class A liver function, or tumor size.